Back
ProQR Therapeutics NV Vs. Lyell Immunopharma, Inc. Industry Stock Comparison
Buy
59
PRQR
ProQR Therapeutics NV
Last Price:
$2.03
Seasonality Move:
13.33%
Buy
57
LYEL
Lyell Immunopharma, Inc.
Last Price:
$36.08
Seasonality Move:
-22.7%
Buy
59
ProQR Therapeutics NV (PRQR)
is a Buy
Is ProQR Therapeutics NV a Buy, Sell or Hold?
-
The current ProQR Therapeutics NV [PRQR] share price is $2.17. The Score for PRQR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
-
PRQR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
57
Lyell Immunopharma, Inc. (LYEL)
is a Buy
Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?
-
The current Lyell Immunopharma, Inc. [LYEL] share price is $35.09. The Score for LYEL is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.
-
LYEL is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PRQR Stock Price Chart
What is ProQR Therapeutics NV's stock price today?
-
The ProQR Therapeutics NV share price today is $2.17The current trend is moderately bullish and PRQR is experiencing selling pressure, which indicates risk of future bearish movement.
LYEL Stock Price Chart
What is Lyell Immunopharma, Inc.'s stock price today?
-
The Lyell Immunopharma, Inc. share price today is $35.09Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing selling pressure, which indicates risk of future bearish movement.
PRQR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.59 | Buy |
| Relative Strength Index (14 RSI): | 47.75 | Sell |
| Chaikin Money Flow: | -590201 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.07 - 2.31) | Sell |
| Bollinger Bands (100): | (2.03 - 2.53) | Sell |
LYEL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.23 | Buy |
| Relative Strength Index (14 RSI): | 66.16 | Buy |
| Chaikin Money Flow: | -92149 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.48 - 34.66) | Buy |
| Bollinger Bands (100): | (10.81 - 25.25) | Buy |
PRQR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.18 | Sell |
| 20-day SMA: | 2.19 | Sell |
| 50-day SMA: | 2.35 | Sell |
| 200-day SMA: | 2.02 | Buy |
| 8-day EMA: | 1.8 | Buy |
| 20-day EMA: | 1.09 | Buy |
| 50-day EMA: | 0.53 | Buy |
| 200-day EMA: | 0.15 | Buy |
LYEL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.85 | Buy |
| 20-day SMA: | 30.4 | Buy |
| 50-day SMA: | 22.87 | Buy |
| 200-day SMA: | 13.87 | Buy |
| 8-day EMA: | 35.03 | Buy |
| 20-day EMA: | 31.05 | Buy |
| 50-day EMA: | 24.98 | Buy |
| 200-day EMA: | 18 | Buy |
ProQR Therapeutics NV Earnings Growth & PRQR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and a decrease next year of $0.08 per share.
Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.
ProQR Therapeutics NV Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Lyell Immunopharma, Inc. Technical Analysis
| Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||